A carregar...
Tyrosine kinase inhibitor-induced hypertension—marker of anti-tumour treatment efficacy or cardiovascular risk factor?
Tyrosine kinase receptor inhibitors (TKIs) are a relatively new class of targeted anti-cancer agents with vascular endothelial growth factor signalling pathway–inhibiting properties. Hypertension is recognized as one of the most common adverse effects of this anti-angiogenic therapy and is the conse...
Na minha lista:
| Publicado no: | Clin Kidney J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857807/ https://ncbi.nlm.nih.gov/pubmed/33564402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfaa174 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|